Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
48,821,304
-
Total 13F shares
-
20,890,957
-
Share change
-
-192,902
-
Total reported value
-
$42,845,289
-
Price per share
-
$2.05
-
Number of holders
-
37
-
Value change
-
-$4,124,677
-
Number of buys
-
18
-
Number of sells
-
19
Institutional Holders of Werewolf Therapeutics, Inc. - Common Stock (HOWL) as of Q4 2022
As of 31 Dec 2022,
Werewolf Therapeutics, Inc. - Common Stock (HOWL) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,890,957 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., MPM ASSET MANAGEMENT LLC, BIOIMPACT CAPITAL LLC, Rubric Capital Management LP, BANK OF AMERICA CORP /DE/, PFM Health Sciences, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., MILLENNIUM MANAGEMENT LLC, SPHERA FUNDS MANAGEMENT LTD., and DC Funds, LP.
This page lists
37
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.